Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taussig

Showing results (531-540 of 561) with videos related to

Pageof 57
Sort By:
The New England Journal of Medicine|May 12, 2006
Long-term inhaled corticosteroids in preschool children at high risk for asthmaTheresa W Guilbert, Wayne J Morgan, Robert S Zeiger, et al.
British Journal of Haematology|March 11, 2024
Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopeniasGrzegorz Pietka, Corinne De Lord, Gwynn Matthias, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2021
Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain InjuryEdward J Needham, Oda Stoevesandt, Eric P Thelin, et al.
Lancet (London, England)|February 18, 2011
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trialFernando D Martinez, Vernon M Chinchilli, Wayne J Morgan, et al.
The Journal of Allergy and Clinical Immunology|December 5, 2006
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller TrialChristine A Sorkness, Robert F Lemanske, David T Mauger, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Epilepsia Open|October 20, 2022
Predictors of outcomes after surgery for medically intractable insular epilepsy: A systematic review and individual participant data meta-analysisSami Obaid, Jia-Shu Chen, George M Ibrahim, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 2, 2014
[French guidelines on electroencephalogram]N André-Obadia, P Sauleau, F Cheliout-Heraut, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 19, 2015
Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent AsthmaJoe K Gerald, Lynn B Gerald, Monica M Vasquez, et al.
The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Pageof 57

Showing results (531-540 of 561) with videos related to

Sort By:
Pageof 57
The New England Journal of Medicine|May 12, 2006
Long-term inhaled corticosteroids in preschool children at high risk for asthmaTheresa W Guilbert, Wayne J Morgan, Robert S Zeiger, et al.
British Journal of Haematology|March 11, 2024
Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopeniasGrzegorz Pietka, Corinne De Lord, Gwynn Matthias, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2021
Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain InjuryEdward J Needham, Oda Stoevesandt, Eric P Thelin, et al.
Lancet (London, England)|February 18, 2011
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trialFernando D Martinez, Vernon M Chinchilli, Wayne J Morgan, et al.
The Journal of Allergy and Clinical Immunology|December 5, 2006
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller TrialChristine A Sorkness, Robert F Lemanske, David T Mauger, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Epilepsia Open|October 20, 2022
Predictors of outcomes after surgery for medically intractable insular epilepsy: A systematic review and individual participant data meta-analysisSami Obaid, Jia-Shu Chen, George M Ibrahim, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 2, 2014
[French guidelines on electroencephalogram]N André-Obadia, P Sauleau, F Cheliout-Heraut, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 19, 2015
Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent AsthmaJoe K Gerald, Lynn B Gerald, Monica M Vasquez, et al.
The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Pageof 57